During the past decade, Chronic Care Center conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chronic Care Center" #1 sponsor was "Celgene" with 3 trials, followed by "HemaQuest Pharmaceuticals Inc." with 3 trials sponsored, "Agios Pharmaceuticals, Inc." with 2 trials sponsored, "Imara, Inc." with 2 trials sponsored and "Protagonist Therapeutics, Inc." with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chronic Care Center" #1 collaborator was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 2 trials as a collaborator and "HemaQuest Pharmaceuticals Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Chronic Care Center" are "Sickle Cell Disease" (3 trials), "Beta Thalassemia Intermedia" (2 trials), "Beta-Thalassemia" (2 trials), "Hemoglobin S Disease" (2 trials) and "Ineffective Erythropoiesis" (2 trials). Many other conditions were trialed in "Chronic Care Center" in a lesser frequency.

Most popular intervention types in "Chronic Care Center" are "Drug" (15 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "HQK-1001" (3 trials), "Luspatercept" (3 trials), "IMR-687" (2 trials) and "Mitapivat" (2 trials). Other intervention names were less common.

The vast majority of trials in "Chronic Care Center" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Chronic Care Center". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Chronic Care Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Chronic Care Center, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".